FOR HEALTHCARE PROFESSIONALS ONLY

This website is a global information resource. It is intended for healthcare professionals only outside of the United States of America (US) who are interested in information on Foundation Medicine®. This site is not intended to provide medical advice and/or treatment guidance. If you are a US healthcare professional click here.

This site is produced by Roche as a partner of Roche Foundation Medicine.

Orange

 

 

 

FoundationOne®Heme je potvrđen sveobuhvatni genski test za hematološke malignitete i sarkome uključujući, ali bez ograničavanja na: leukemije, mijelodisplastični sindrom, mijeloproliferativne neoplazme, limfome, multipli mijelom, Ewingov sarkom i leiomiosarkom.

Narudžba

Narudžba FoundationOne Heme

Prihvatljivi tipovi uzorka su parafinski blok, periferna krv i koštana srž. Uzorak krvi i koštane srži se moraju primiti na analizu najkasnije dan nakon prikupljanja.

FFPE U formalinu fiksirano, u parafin uklopljeno tkivo. MSI Mikrosatelitna nestabilnost. TMB mutacijsko opterećenje tumora.
References
  1. FoundationOne®Heme Technical Specifications, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).
  2. FoundationOne®Heme Specimen Instructions, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).